PAR-1 is increased on SSc-associated ILD myofibroblasts, and when it is inhibited by the direct thrombin inhibitor, dabigatran, there is abrogation of formation of myofibroblasts, αSMA, and production of CI (463). This evidence concerns the gene ACTA1 and systemic sclerosis.